Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States - PubMed (original) (raw)

Multicenter Study

Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States

Yuan Lu et al. J Am Heart Assoc. 2018.

Abstract

Background: The reasons for China's high stroke prevalence are not well understood. The cardiovascular risk factor profiles of China and the United States have not been directly compared in nationally representative population samples.

Methods and results: Using data from the CHARLS (China Health and Retirement Longitudinal Study) and the NHANES (US National Health and Nutrition Examination Survey), we compared cardiovascular risk factors from 2011 to 2012 among people aged 45 to 75 years between the 2 countries (China, 12 654 people; United States, 2607 people): blood pressure, cholesterol, body mass index, waist circumference, fasting plasma glucose, hemoglobin A1c, and high-sensitivity C-reactive protein. Compared with the United States, China had a lower prevalence of hypertension but a higher mean blood pressure and a higher proportion of patients with severe hypertension (≥160/100 mm Hg) (10.5% versus 4.5%). China had substantially lower rates of hypertension treatment (46.8% versus 77.9%) and control (20.3% versus 54.7%). Dyslipidemia was less common in China, but lipid levels were not significantly different because dyslipidemia awareness and control rates in China were 3- and 7-fold lower than US rates, respectively. High-sensitivity C-reactive protein, body mass index, and waist circumference were significantly lower in China than in the United States. Clustering of hypertension with other cardiovascular risk factors was more common in China.

Conclusions: Hypertension is more common in the United States, but blood pressure levels are higher in China, which may be responsible for China's high stroke prevalence. The low rates of awareness, treatment, and control of hypertension provide an exceptional opportunity for China to reduce risk in its population.

Keywords: cardiovascular diseases prevention; cardiovascular diseases risk factors; global disparities; international comparison.

PubMed Disclaimer

Figures

Figure 1

Distribution of blood pressure (A), lipids (B), and fasting plasma glucose (C), by treatment status, in China and the United States (

), from 2011 to 2012. HDL indicates high‐density lipoprotein; and LDL, low‐density lipoprotein.

Figure 2

Prevalence of dyslipidemia (we defined dyslipidemia as total cholesterol [TC] ≥240 mg/dL, low‐density lipoprotein [LDL‐C] cholesterol ≥160 mg/dL, high‐density lipoprotein [HDL‐C] cholesterol <40 mg/dL, triglycerides [TG] ≥200 mg/dL, or taking lipid‐modifying medications, according to the 2007 Chinese guidelines on the prevention and treatment of dyslipidemia) and prevalence of each component, in China and the United States (US), from 2011 to 2012.

Figure 3

Mean fasting plasma glucose and prevalence of diabetes mellitus, in China and the United States (US), from 2011 to 2012.

Figure 4

Mean body mass index (

BMI

) and prevalence of

BMI

categories, in China and the United States (US), from 2011 to 2012.

Figure 5

Distribution of high‐sensitivity C‐reactive protein (high‐sensitivity C‐reactive protein data are from

NHANES

[US National Health and Nutrition Examination Survey] 2009–2010, because they were unavailable in

NHANES

2011–2012), in China and the United States (

), from 2011 to 2012.

Figure 6

Clustering of cardiometabolic risk factors (hypertension, dyslipidemia, diabetes mellitus, overweight, and obesity) in China and the United States (US), from 2011 to 2012.

References

1. Abubakar I, Tillmann T, Banerjee A. Global, regional, and national age‐sex specific all‐cause and cause‐specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–171. - PMC - PubMed
1. Prospective Studies Collaboration . Age‐specific relevance of usual blood pressure to vascular mortality: a meta‐analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. - PubMed
1. Prospective Studies Collaboration . Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta‐analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet. 2007;370:1829–1839. - PubMed
1. Evans A, Tolonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K; WHO MONICA Project . Trends in coronary risk factors in the WHO MONICA project. Int J Epidemiol. 2001;30(suppl 1):S35–S40. - PubMed
1. Gu D, Gupta A, Muntner P, Hu S, Duan X, Chen J, Reynolds RF, Whelton PK, He J. Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia). Circulation. 2005;112:658–665. - PubMed

Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States - PubMed (original) (raw)